stars 1 stars 2 stars 3

View BrainBits LLC's top competitors like Axon Neuropsychological Services, Cortex Labs, and Mindreach Consulting.

NeuroScience
Established in the Saint Croix River Valley near Osceola, Wisconsin in 2000 as a professional grade dietary supplement company, NeuroScience began offering proprietary blends of amino acids designed specifically to provide precursors for nervous system molecules called neurotransmitters. After nearly two decades, NeuroScience is recognized as a top pro-grade brand delivering premium products containing amino acids, botanicals, vitamins, and minerals exclusively to thousands of licensed healthcare providers.
Osceola, Wisconsin, US
Private
$5.6M Revenue
http://www.neuroscienceinc.com
142 Employees
NervGen Pharma Corp.
NervGen Pharma Corp. (TSXV: NGEN) (NASDAQ: NGEN) is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. The Company’s mission is to transform the lives of individuals living with SCI by enabling the nervous system to repair itself. NervGen’s lead therapeutic candidate, NVG-291, is a subcutaneously administered, neuroreparative peptide. NVG-291 was evaluated in the Phase 1b/2a CONNECT SCI Study in individuals with chronic SCI between 1 to 10 years post-injury and is the first pharmacologic candidate to demonstrate durable improvement in function, independence, and quality of life. Enrollment of individuals with subacute SCI in the Phase 1b/2a CONNECT SCI Study is ongoing, alongside preparation for a Phase 3 clinical trial in chronic SCI. NVG-291 has received Fast Track designation from the FDA and Orphan Drug designation from the European Medicines Agency (EMA) for the treatment of SCI. Through NVG-291 and the Company’s next-generation candidate, NVG-300, NervGen is pursuing a pharmacologic approach to transform the treatment paradigm for neurotraumatic and neurologic conditions with significant unmet medical need.
Vancouver, CA
Public
$924K Revenue
http://www.nervgen.com
13 Employees
NGEN Ticker
NeuroNexus
NeuroNexus is a global leader for innovative neural interface products and technologies to meet both current and upcoming needs in neuroscience research, neurosurgery, and neuromodulation. NeuroNexus powers neuroscience research through innovative neural probes, systems, and data analytics software. NeuroNexus probes include a full line of high-quality, customizable microelectrode arrays for electrophysiology and optogenetics research. NeuroNexus systems provide integrated plug-and-play solutions to support diverse neurophysiology experiments and workflows. The NeuroNexus data analytics software platform provides powerful, scalable, cross-platform analytical and visualization tools for managing and analyzing neurophysiological data -- from individual experiments to complex multi-investigator 'big data'.
Ann Arbor, Michigan, US
Private
$6.2M Revenue
http://www.neuronexus.com
35 Employees

Top BrainBits LLC Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users